Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) EBITDA (2021 - 2026)

Canton Strategic Holdings' (CNTN) quarterly EBITDA came in at -$36.9 million in Q1 2026, down 1347.71% YoY from $3.0 million in Q1 2025, and down 170.8% on a QoQ basis from -$13.6 million in Q4 2025.

Analysis

Canton Strategic Holdings (CNTN) EBITDA (2021 - 2026) Analysis & Trends

Canton Strategic Holdings (CNTN) has 6 years of EBITDA data on file, last reported at -$36.9 million in Q1 2026.

  • Quarterly EBITDA fell 1347.71% year-over-year to -$36.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$54.4 million (down 331.99% YoY) and the FY2025 annual result came in at -$20.1 million, down 62.15% from the prior year.
  • EBITDA eased to -$36.9 million in Q1 2026, from -$13.6 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of -$1.4 million in Q1 2022 to a low of -$36.9 million in Q1 2026.
  • A 5-year average of -$5.0 million and a median of -$2.4 million in 2023 frame the typical range for EBITDA.
  • Annual changes were most pronounced in 2022 — EBITDA slumped 1638.74% — and 2025, when it jumped 45.84%.
  • Tracing CNTN's EBITDA over 5 years: stood at -$1.8 million in 2022, then plunged by 43.29% to -$2.5 million in 2023, then slumped by 50.67% to -$3.8 million in 2024, then sank by 257.0% to -$13.6 million in 2025, then slumped by 170.8% to -$36.9 million in 2026.
  • The last three EBITDA figures came in at -$36.9 million (Q1 2026), -$13.6 million (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 493.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -815.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -505.13 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 325.05 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 231.44 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 133.12 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -1.55 Mn
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn - -1.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.20 Mn
Mar 31, 2026 -36.87 Mn
Dec 31, 2025 -13.61 Mn
Sep 30, 2025 -2.09 Mn
Jun 30, 2025 -1.43 Mn
Mar 31, 2025 -2.55 Mn
Dec 31, 2024 -3.85 Mn
Sep 30, 2024 -3.87 Mn
Jun 30, 2024 -2.37 Mn
Mar 31, 2024 -2.35 Mn
Dec 31, 2023 -2.53 Mn
Sep 30, 2023 -1.85 Mn
Jun 30, 2023 -2.36 Mn
Mar 31, 2023 -2.71 Mn
Dec 31, 2022 -1.77 Mn
Sep 30, 2022 -2.13 Mn
Jun 30, 2022 -1.64 Mn
Mar 31, 2022 -1.35 Mn
Dec 31, 2021 -101,593.00
Sep 30, 2021 -541,113.00